Fedenia Advisers LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fedenia Advisers LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 56.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,106 shares of the medical equipment provider's stock after purchasing an additional 759 shares during the quarter. Fedenia Advisers LLC's holdings in Intuitive Surgical were worth $1,043,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. AlphaCore Capital LLC lifted its stake in shares of Intuitive Surgical by 4.2% in the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after purchasing an additional 18 shares during the last quarter. Accredited Investors Inc. raised its holdings in Intuitive Surgical by 1.9% during the 4th quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock valued at $543,000 after buying an additional 19 shares during the period. Second Line Capital LLC lifted its position in Intuitive Surgical by 3.4% in the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after buying an additional 19 shares during the last quarter. Colonial Trust Co SC lifted its position in Intuitive Surgical by 8.8% in the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock worth $128,000 after buying an additional 20 shares during the last quarter. Finally, Crown Wealth Group LLC boosted its stake in Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after buying an additional 20 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $2.61 during trading hours on Wednesday, reaching $540.60. The stock had a trading volume of 1,487,420 shares, compared to its average volume of 1,668,652. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The firm's 50 day moving average is $534.76 and its 200-day moving average is $536.73. The stock has a market capitalization of $193.76 billion, a price-to-earnings ratio of 79.27, a P/E/G ratio of 5.76 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the company posted $1.50 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the business's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president directly owned 5,224 shares in the company, valued at $2,695,113.84. The trade was a 3.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock worth $2,611,577 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ISRG. Barclays lowered their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Truist Financial lowered their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price objective for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.